Protalix BioTherapeutics Reports Second Quarter 2024 Financial and Business Results
Protalix BioTherapeutics Reports Second Quarter 2024 Financial and Business Results Company to host conference call and webcast today at 8:30...
Quarter
MindMed Reports Second Quarter 2024 Financial Results and Business Updates
--Completed End-of-Phase 2 (EOP2) meeting with the U.S. Food and Drug Administration (FDA); on track to initiate Phase 3 clinical...
